Human Cardiac Organoids for Disease Modeling.

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Traditional 2D cell cultures and animal models present limitations in human cardiac drug discovery and disease modeling.
• These limitations include challenges in recapitulating cellular complexity and achieving animal-to-human translation.
• Existing models struggle to maintain differentiated cell functions over extended periods.

Purpose of the Study:

• To highlight the significance of evolving human cardiac organoid technologies.
• To demonstrate how organoid platforms can overcome current in vitro modeling obstacles.
• To showcase the potential of cardiac organoids for personalized medicine and drug discovery.

Main Methods:

• Development of human cardiac organoids derived from pluripotent stem cells.
• Utilizing patient-derived cells with known genotypes and phenotypes for organoid construction.
• Reviewing and presenting examples of current cardiac organoid platforms.

Main Results:

• Human cardiac organoids closely mimic in vivo organ functions in vitro.
• Organoid platforms provide more complex and robust in vitro tools for disease modeling.
• These platforms enable sustained differentiated cell functions, addressing limitations of conventional models.

Conclusions:

• Human cardiac organoid technologies are crucial for advancing disease biology research.
• Organoid platforms offer a promising avenue for personalized medicine and novel drug discovery.
• The reviewed platforms represent significant progress in in vitro cardiac modeling.